I
n cardiac myocytes, Ca 2ϩ influx and efflux must be in balance to ensure cellular viability, normal contractile function, and a stable heart rhythm. Therefore Ca 2ϩ fluxes between the major cellular compartments and the extracellular space have to adapt to a wide range of changing conditions. Failure to do so can result in Ca 2ϩ overload of the sarcoplasmic reticulum (SR), leading to arrhythmogenic spontaneous release of SR Ca 2ϩ by ryanodine receptors (RyRs). Recently, it was shown that suppressing RyR open probability (P o ) was protective in a mouse model of a congenital arrhythmia caused by increased Ca 2ϩ leak from RyRs. It was suggested that such a strategy could be applied more widely to treat patients with common ventricular arrhythmias. 1 Under normal conditions, Ca 2ϩ enters the cardiomyocyte at the beginning of each contractile cycle through L-type Ca 2ϩ channels (LCCs) and minimally raises the cytoplasmic Ca 2ϩ concentration. This "trigger calcium" binds to RyRs and induces an even greater release of stored Ca 2ϩ from the SR into the cytoplasm, which causes myofilament contraction. Survival of the cell, as well as relaxation, both depend on the reuptake of 75% of the cytoplasmic Ca 2ϩ by SERCA into the SR. 4 Most of the remaining Ca 2ϩ is extruded by the sodium-calcium exchanger (NCX), with minimal amounts of removal by the sarcolemmal Ca 2ϩ pump. The removal of Ca 2ϩ by NCX leaves the cell containing the exact same amount of Ca 2ϩ it started out with. 5 Yet the high gain positive feedback system of Ca 2ϩ -induced Ca 2ϩ release in heart muscle poses a challenge for the maintenance of Ca 2ϩ homeostasis. Calcium released from the SR by RyRs could conceivably spread to and activate all of the other RyRs in the cell, resulting in an asynchronous and slow release of SR Ca 2ϩ (eg, a Ca 2ϩ wave) with each action potential. Stern et al 6 predicted that synchronous contraction, graded release, and stability required "local control," using physical separation of individual Ca 2ϩ release units, or couplons. 7 The "local-control" theory predicts that an increase in Ca 2ϩ current will recruit more release units and thereby increase global SR Ca 2ϩ release to provide an inotropic response. This theory has been supported by the identification of individual . Both of these effects eventually override the inhibitory effects of metabolic stress on the RyR, resulting in spontaneous release of Ca 2ϩ and generation of Ca 2ϩ waves. Ca 2ϩ released into the cytoplasm during a Ca 2ϩ wave is handled by the myocyte in two ways: (1) re-uptake by the SR (assuming SERCA activity remains), and (2) removal from the cell by NCX. Efflux of Ca 2ϩ by NCX generates a transient inward current (I TI ), which is capable of bringing Na ϩ channels to threshold and producing delayed after-depolarizations or DADs. 13 Pogwizd et al 14 demonstrated that most ventricular arrhythmias in non-ischemic cardiomyopathy are initiated by non-reentrant mechanisms, exemplified by DADs. And up to 50% of ventricular arrhythmias in ischemic cardiomyopathy may be initiated by after-depolarizations, though the proportions remain controversial. 15 Amazingly, despite reductions in SERCA expression and increases in NCX expression, increased catecholamine levels in heart failure lead to SR Ca 2ϩ
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overload and DADs. 16 The use of beta agonists in the treatment of systolic failure further increases SR Ca 2ϩ load and risk of DADs, likely explaining the arrhythmogenicity of these drugs and the poor outcomes associated with their clinical use. 17 It has also been suggested that increased leak of Ca 2ϩ from the SR during diastole in the setting of heart failure 18 can trigger Ca 2ϩ waves and therefore DADs. Finally, several well-defined genetic mutations of the RyR and its associated proteins lead to increased RyR P o and therefore DADs. In particular, dissociation of the accessory protein calstabin2 has been shown to occur in patients with catecholaminergic polymorphic ventricular tachycardia (CPVT), and these patients are predisposed to triggered arrhythmias. 1, 19 Can homeostasis be achieved in the setting of Ca In a mouse model of CPVT, arrhythmia frequency can be reduced by using an experimental compound, JTV519, to enhance the binding of calstabin2 to RyR2 and thus reduce RyR P o . 1 Venetucci et al use the drug tetracaine to apply a similar strategy to reduce spontaneous Ca 2ϩ release in cells overloaded with Ca 2ϩ (and thus prone to increased RyR P o ) during exposure to isoproterenol.
Tetracaine is a local anesthetic with Na ϩ channel blocking properties. However, unlike related local anesthetics such as lidocaine, tetracaine has the additional effect of reducing RyR P o . 20 Venetucci et al 2 transient would appear to be an ideal strategy to both strengthen contraction and reduce arrhythmias in patients with heart failure. A note of caution must be sounded, however. Although afterdepolarizations likely trigger the majority of lethal ventricular arrhythmias in heart failure, and perhaps in ischemia as well, pharmacological suppression of arrhythmia triggers (eg, PVCs) has not been a successful strategy in clinical trials, 21 presumably because of unintended changes in the electrophysiological milieu of the myocardium. Thus, suppressing arrhythmia triggers may not be a sufficient antiarrhythmic strategy. It is more likely that modulating parameters that are known to maintain reentrant arrhythmias, such as restitution slope, 22 is also an essential component of arrhythmia suppression.
